Dianthus TherapeuticsDNTH
13F holders, Q1 2026 (March 31)241holders +75
90new positions
18sold out
6famous investors
$83.28avg. 13F price*
At the end of Q1 2026, 241 institutions reported holding Dianthus Therapeutics Inc. (DNTH) in their 13F filings, up 75 from Q4 2025. 90 opened new positions and 18 sold out. The largest holders were FMR LLC ($651.9M), BlackRock, Inc. ($266.5M) and Ra Capital Management, L.P. ($219.2M). 6 famous investors held it, including Steve Cohen (0.1% of Point72 Asset Management's portfolio), Ken Griffin (0.1% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Dianthus Therapeutics Inc.
- CUSIP
- 252828108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 90 | $773.0M |
| Exits | 18 | $29.8M |
All 13F filers, Q4 2025 → Q1 2026: 19,310,574 shares bought and 6,614,301 shares sold, net +12,696,273 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 241 holders
| FMR LLC | 0.03% | Add +20.8% | 7,767,686 | $651.9M |
| BlackRock, Inc. | 0.00% | Add +65.8% | 3,175,703 | $266.5M |
| Ra Capital Management, L.P. | 2.32% | Add +62.0% | 2,611,733 | $219.2M |
| Wellington Management Group LLP | 0.04% | Add +3.7% | 2,595,783 | $217.8M |
| Fairmount Funds Management LLC | 15.38% | Add +18.7% | 2,537,191 | $212.9M |
| Avidity Partners Management LP | 35.76% | No change | 2,104,184 | $176.6M |
| Vanguard Capital Management LLC | 0.00% | — | 2,031,249 | $170.5M |
| Octagon Capital Advisors LP | 18.08% | Reduce -19.4% | 1,946,667 | $163.4M |
| TCG Crossover Management, LLC | 4.03% | No change | 1,676,624 | $140.7M |
| Citadel Advisors | 0.10% | Add +50.7% | 1,610,483 | $135.2M |
| State Street Corp. | 0.00% | Reduce -7.2% | 1,398,913 | $117.4M |
| T. Rowe Price Investment Management, Inc. | 0.07% | New | 1,292,182 | $108.4M |
| Venrock Adviser, LLC | 3.70% | Add +18.0% | 1,180,000 | $99.0M |
| Fred Alger Management, LLC | 0.43% | Add +3372.6% | 1,161,923 | $97.5M |
| T. Rowe Price Associates Inc. | 0.01% | Add +86.2% | 1,146,948 | $96.3M |
| Polar Capital Holdings Plc | 0.39% | Add +7.1% | 1,076,009 | $90.3M |
| Deerfield Management Company, L.P. | 1.19% | New | 1,019,813 | $85.6M |
| Franklin Resources Inc. | 0.02% | Add +109.2% | 968,182 | $81.2M |
| Cormorant Asset Management, LP | 4.02% | New | 950,000 | $79.7M |
| Geode Capital Management, LLC | 0.00% | Add +35.4% | 916,211 | $76.9M |
| Braidwell LP | 2.87% | Reduce -29.4% | 899,364 | $75.5M |
| Baker Bros. Advisors LP | 0.41% | Add +7.9% | 852,164 | $71.5M |
| Farallon Capital Management, L.L.C. | 0.42% | New | 836,000 | $70.2M |
| UBS Group AG | 0.01% | Add +28.8% | 781,282 | $65.6M |
| Silverarc Capital Management, LLC | 6.47% | Reduce -12.7% | 654,746 | $54.9M |
| Point72 Asset Management | 0.10% | Reduce -44.8% | 643,599 | $54.0M |
| Catalio Capital Management, LP | 9.82% | Reduce -14.3% | 560,308 | $47.0M |
| Goldman Sachs Group Inc. | 0.01% | Reduce -5.0% | 548,010 | $46.0M |
| Jennison Associates LLC | 0.03% | New | 485,136 | $40.7M |
| Balyasny Asset Management L.P. | 0.08% | New | 474,085 | $39.8M |
| Alliancebernstein L.P. | 0.01% | Add +11.0% | 926,071 | $38.2M |
| Woodline Partners LP | 0.14% | Add +103.4% | 433,457 | $36.4M |
| Samlyn Capital, LLC | 0.62% | New | 431,115 | $36.2M |
| Ameriprise Financial Inc. | 0.01% | Add +176.6% | 429,127 | $36.0M |
| MPM Bioimpact LLC | 2.75% | New | 423,982 | $35.6M |
| Logos Global Management LP | 1.73% | Add +27.0% | 400,000 | $33.6M |
| Artisan Partners Limited Partnership | 0.05% | New | 382,121 | $32.1M |
| Barclays PLC | 0.01% | Add +115.3% | 379,606 | $31.9M |
| Spruce Street Capital LP | 7.53% | Add +25.5% | 373,274 | $31.3M |
| Sio Capital Management, LLC | 4.48% | Reduce -22.0% | 370,045 | $31.1M |
| Bain Capital Life Sciences Investors, LLC | 2.75% | Reduce -51.3% | 362,470 | $30.4M |
| Vivo Capital, LLC | 2.47% | No change | 353,998 | $29.7M |
| Affinity Asset Advisors, LLC | 1.76% | Add +204.3% | 350,000 | $29.4M |
| Vanguard Portfolio Management LLC | 0.00% | — | 349,381 | $29.3M |
| Marshall Wace, LLP | 0.03% | Reduce -66.1% | 341,929 | $28.7M |
| Dimensional Fund Advisors LP | 0.01% | Add +54.5% | 325,440 | $27.3M |
| Driehaus Capital Management LLC | 0.20% | New | 317,312 | $26.6M |
| Charles Schwab Investment Management Inc. | 0.00% | Add +21.8% | 305,440 | $25.6M |
| Northern Trust Corp. | 0.00% | Add +46.6% | 303,752 | $25.5M |
| Lord, Abbett & Co. LLC | 0.09% | New | 299,210 | $25.1M |
| Tang Capital Management LLC | 1.13% | No change | 264,692 | $22.2M |
| Millennium Management | 0.02% | Reduce -60.7% | 261,962 | $22.0M |
| Vanguard Fiduciary Trust Co. | 0.01% | — | 249,679 | $21.0M |
| RTW Investments, LP | 0.21% | New | 248,063 | $20.8M |
| Freestone Grove Partners LP | 0.15% | New | 239,943 | $20.1M |
| BNP Paribas Financial Markets | 0.01% | Reduce -50.5% | 235,748 | $19.8M |
| Eventide Asset Management, LLC | 0.31% | New | 225,261 | $18.9M |
| First Turn Management, LLC | 2.07% | New | 220,921 | $18.5M |
| Nuveen, LLC | 0.01% | Add +14.1% | 217,482 | $18.3M |
| Candriam S.C.A. | 0.09% | Reduce -31.4% | 213,522 | $17.9M |
| Ensign Peak Advisors, Inc | 0.03% | Add +52.0% | 204,336 | $17.1M |
| Jefferies Financial Group Inc. | 0.21% | New | 202,410 | $17.0M |
| Bank of America Corp. | 0.00% | Reduce -59.5% | 188,779 | $15.8M |
| Bank of New York Mellon Corp | 0.00% | Add +150.8% | 188,412 | $15.8M |
| PFM Health Sciences, LP | 1.55% | Add +72.9% | 172,137 | $14.4M |
| Artia Global Partners LP | 3.08% | Reduce -20.5% | 162,990 | $13.7M |
| Adage Capital Partners Gp, L.L.C. | 0.02% | New | 160,000 | $13.4M |
| Walleye Capital LLC | 0.09% | Reduce -25.4% | 153,585 | $12.9M |
| Integral Health Asset Management, LLC | 0.67% | Reduce -45.5% | 150,000 | $12.6M |
| D. E. Shaw & Co. | 0.01% | Reduce -3.3% | 149,609 | $12.6M |
| Tri Locum Partners LP | 1.71% | Reduce -76.6% | 145,543 | $12.2M |
| Invesco Ltd. | 0.00% | Add +28.8% | 130,747 | $11.0M |
| Russell Investments Group, Ltd. | 0.01% | Add +46.2% | 129,065 | $10.8M |
| Atika Capital Management LLC | 1.71% | Reduce -4.3% | 128,800 | $10.8M |
| TD Asset Management Inc | 0.01% | Add +267.2% | 116,576 | $9.8M |
| LMR Partners LLP | 0.12% | New | 116,444 | $9.8M |
| Hudson Bay Capital Management LP | 0.06% | New | 109,238 | $9.2M |
| Atom Investors LP | 0.65% | Reduce -40.8% | 107,753 | $9.0M |
| SummitTX Capital, L.P. | 0.27% | Add +13.8% | 100,044 | $8.4M |
| Seven Grand Managers, LLC | 0.56% | New | 100,000 | $8.4M |
| Morgan Stanley | 0.00% | Reduce -57.3% | 97,455 | $8.2M |
| Cinctive Capital Management LP | 0.52% | Add +105.7% | 94,408 | $7.9M |
| Patient Square Capital LP | 1.40% | Reduce -37.4% | 93,882 | $7.9M |
| Sei Investments Co. | 0.01% | Add +566.4% | 92,229 | $7.7M |
| ExodusPoint Capital Management, LP | 0.07% | Reduce -65.3% | 85,530 | $7.2M |
| Stempoint Capital LP | 1.38% | Add +7.8% | 85,502 | $7.2M |
| Moody Aldrich Partners LLC | 1.24% | Add +98.8% | 82,129 | $6.9M |
| Rhenman & Partners Asset Management AB | 0.85% | Reduce -17.2% | 81,627 | $6.9M |
| Susquehanna International Group, LLP | 0.01% | Add +55.4% | 80,001 | $6.7M |
| American Century Companies Inc. | 0.00% | Add +8.7% | 79,096 | $6.6M |
| Informed Momentum Co LLC | 0.74% | Reduce -9.4% | 76,640 | $6.4M |
| Schonfeld Strategic Advisors LLC | 0.05% | Reduce -59.8% | 73,468 | $6.2M |
| Swiss National Bank | 0.00% | Add +119.8% | 69,000 | $5.8M |
| Nantahala Capital Management, LLC | 0.35% | Reduce -82.1% | 67,282 | $5.6M |
| Manufacturers Life Insurance Company, The | 0.00% | Add +154.9% | 65,238 | $5.5M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Add +400.6% | 60,435 | $5.1M |
| Trexquant Investment LP | 0.04% | Add +1032.6% | 59,077 | $5.0M |
| Neuberger Berman Group LLC | 0.00% | Reduce -32.7% | 59,076 | $5.0M |
| ADAR1 Capital Management, LLC | 0.28% | New | 55,000 | $4.6M |
| Seven Fleet Capital Management LP | 1.43% | Add +270.3% | 54,258 | $4.6M |
"% of holder's portfolio" is DNTH's weight in each manager's 13F, not the share of Dianthus Therapeutics Inc. the manager owns.